Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Lappe Mark. Director active across 2 companies, notably Inhibrx, Inc.. In total, 11 reports have been logged. Breakdown: 4 buys · 5 sells. Total volume traded: €2.7m. History available since 17 October 2022. The latest transaction was disclosed on 12 September 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lappe Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8,981 shares@ US$28.66260.4% of flowCommon StockSEC:0001739614-22-000107:0
11 of 11 declarations
About Lappe Mark
Lappe Mark is Chief Executive Officer at Inhibrx, Inc. and Inhibrx Biosciences, Inc. He has filed 11 filings, and across the sampled recent filings held, buys total EUR 1166051 and sells total EUR 70382436, from 2022-10-18 to 2024-09-16; the most frequent transaction nature is Cession.